30 related articles for article (PubMed ID: 10222114)
1. Nigrostriatal neuronal death following chronic dichlorvos exposure: crosstalk between mitochondrial impairments, α synuclein aggregation, oxidative damage and behavioral changes.
Binukumar BK; Bal A; Kandimalla RJ; Gill KD
Mol Brain; 2010 Nov; 3():35. PubMed ID: 21073741
[TBL] [Abstract][Full Text] [Related]
2. Effects of tempol and redox-cycling nitroxides in models of oxidative stress.
Wilcox CS
Pharmacol Ther; 2010 May; 126(2):119-45. PubMed ID: 20153367
[TBL] [Abstract][Full Text] [Related]
3. Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress.
Press C; Milbrandt J
J Neurosci; 2008 May; 28(19):4861-71. PubMed ID: 18463239
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease.
Sherer TB; Richardson JR; Testa CM; Seo BB; Panov AV; Yagi T; Matsuno-Yagi A; Miller GW; Greenamyre JT
J Neurochem; 2007 Mar; 100(6):1469-79. PubMed ID: 17241123
[TBL] [Abstract][Full Text] [Related]
5. Experimental strategy to identify genes susceptible to oxidative stress in nigral dopaminergic neurons.
Yoo MS; Kawamata H; Kim DJ; Chun HS; Son JH
Neurochem Res; 2004 Jun; 29(6):1223-34. PubMed ID: 15176479
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease.
Toulmond S; Tang K; Bureau Y; Ashdown H; Degen S; O'Donnell R; Tam J; Han Y; Colucci J; Giroux A; Zhu Y; Boucher M; Pikounis B; Xanthoudakis S; Roy S; Rigby M; Zamboni R; Robertson GS; Ng GY; Nicholson DW; Flückiger JP
Br J Pharmacol; 2004 Feb; 141(4):689-97. PubMed ID: 14744804
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of toxicity in rotenone models of Parkinson's disease.
Sherer TB; Betarbet R; Testa CM; Seo BB; Richardson JR; Kim JH; Miller GW; Yagi T; Matsuno-Yagi A; Greenamyre JT
J Neurosci; 2003 Nov; 23(34):10756-64. PubMed ID: 14645467
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic approaches to Parkinson's disease pathogenesis.
Betarbet R; Sherer TB; Di Monte DA; Greenamyre JT
Brain Pathol; 2002 Oct; 12(4):499-510. PubMed ID: 12408237
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide: an antioxidant and neuroprotector.
Mohanakumar KP; Thomas B; Sharma SM; Muralikrishnan D; Chowdhury R; Chiueh CC
Ann N Y Acad Sci; 2002 May; 962():389-401. PubMed ID: 12076990
[TBL] [Abstract][Full Text] [Related]
10. Potent neuroprotective and antioxidant activity of apomorphine in MPTP and 6-hydroxydopamine induced neurotoxicity.
Grünblatt E; Mandel S; Gassen M; Youdim MB
J Neural Transm Suppl; 1999; 55():57-70. PubMed ID: 10335493
[TBL] [Abstract][Full Text] [Related]
11. Novel free radical spin traps protect against malonate and MPTP neurotoxicity.
Matthews RT; Klivenyi P; Mueller G; Yang L; Wermer M; Thomas CE; Beal MF
Exp Neurol; 1999 May; 157(1):120-6. PubMed ID: 10222114
[TBL] [Abstract][Full Text] [Related]
12. Azulenyl nitrone spin traps protect against MPTP neurotoxicity.
Klivenyi P; Matthews RT; Wermer M; Yang L; MacGarvey U; Becker DA; Natero R; Beal MF
Exp Neurol; 1998 Jul; 152(1):163-6. PubMed ID: 9682023
[TBL] [Abstract][Full Text] [Related]
13. A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities.
Yang L; Calingasan NY; Chen J; Ley JJ; Becker DA; Beal MF
Exp Neurol; 2005 Jan; 191(1):86-93. PubMed ID: 15589515
[TBL] [Abstract][Full Text] [Related]
14. S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity.
Matthews RT; Yang L; Beal MF
Exp Neurol; 1997 Feb; 143(2):282-6. PubMed ID: 9056390
[TBL] [Abstract][Full Text] [Related]
15. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
